Sign in

CIK 0000914475

  • Large accelerated filer

NEUROCRINE BIOSCIENCES INC

Sign in to watch
Ticker
NBIX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330525145
Phone
+1 858-617-7600
Business address
6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,162,347
in 4 filings, $3.2M under 10b5-1 plans

Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-05-05 RASTETTER WILLIAM H Director Sale 10b5-1 −30,000 $110.20 $3.3M 37,491
2025-05-05 RASTETTER WILLIAM H Director Option exercise · Non-Qualified Stock Option 10b5-1 −30,000 0
2025-02-14 ROBERTS EIRY Chief Medical Officer Sale 10b5-1 −500 $115.04 $58K 35,640
2025-02-13 Cooke Julie Chief Human Resources Officer Option exercise 10b5-1 +1,509 20,340
2025-02-13 Cooke Julie Chief Human Resources Officer Sale 10b5-1 −796 $116.77 $93K 19,544
2025-02-13 Cooke Julie Chief Human Resources Officer Option exercise 10b5-1 +1,401 20,945
2025-02-13 Cooke Julie Chief Human Resources Officer Sale 10b5-1 −755 $116.80 $88K 20,190
2025-02-13 Cooke Julie Chief Human Resources Officer Option exercise · Restricted Stock Unit 10b5-1 −1,509 3,020
2025-02-13 Cooke Julie Chief Human Resources Officer Option exercise · Restricted Stock Unit 10b5-1 −1,401 4,203
2025-02-13 GORMAN KEVIN CHARLES Director Option exercise 10b5-1 +5,376 524,450
2025-02-13 GORMAN KEVIN CHARLES Director Sale 10b5-1 −2,832 $116.69 $330K 521,618
2025-02-13 GORMAN KEVIN CHARLES Director Option exercise 10b5-1 +5,603 527,221
2025-02-13 GORMAN KEVIN CHARLES Director Sale 10b5-1 −3,012 $116.68 $351K 524,209
2025-02-13 GORMAN KEVIN CHARLES Director Option exercise · Restricted Stock Unit 10b5-1 −5,376 10,754
2025-02-13 GORMAN KEVIN CHARLES Director Option exercise · Restricted Stock Unit 10b5-1 −5,603 16,812
2025-02-13 SHERWIN STEPHEN A Director Sale 10b5-1 −13,831 $116.69 $1.6M 10,673
2025-02-13 ROBERTS EIRY Chief Medical Officer Option exercise 10b5-1 +2,113 35,366
2025-02-13 ROBERTS EIRY Chief Medical Officer Sale 10b5-1 −1,114 $116.90 $130K 34,252
2025-02-13 ROBERTS EIRY Chief Medical Officer Option exercise 10b5-1 +1,120 35,372
2025-02-13 ROBERTS EIRY Chief Medical Officer Sale 10b5-1 −604 $116.74 $71K 34,768

Page 20 of 49 · 963 trades